AJP - Endo AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 294: E326-E335, 2008. First published November 27, 2007; doi:10.1152/ajpendo.00296.2007
0193-1849/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/E326    most recent
00296.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, J.
Right arrow Articles by Renaud, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, J.
Right arrow Articles by Renaud, J.-M.

KATP channel-deficient pancreatic β-cells are streptozotocin resistant because of lower GLUT2 activity

Jin Xu,1 Li Zhang,1 Andrew Chou,1 Tim Allaby,1 Guy Bélanger,1 Jerry Radziuk,1,2 Bernard J. Jasmin,1,2 Takashi Miki,3 Susumo Seino,3 and Jean-Marc Renaud1

1Department of Cellular and Molecular Medicine and 2Ottawa Hospital and Ottawa Health Research Institute, University of Ottawa, Ottawa, Canada; and 3Division of Cellular and Molecular Medicine, Graduate School of Medicine, Kobe University, Kobe, Japan

Submitted 15 May 2007 ; accepted in final form 9 November 2007

In wild-type mice, a single injection of streptozotocin (STZ, 200 mg/kg body wt) caused within 4 days severe hyperglycemia, hypoinsulinemia, significant glucose intolerance, loss of body weight, and the disappearance of pancreatic β-cells. However, in ATP-sensitive K+ channel (KATP channel)-deficient mice (Kir6.2–/– mice), STZ had none of these effects. Exposing isolated pancreatic islets to STZ caused severe damage in wild-type but not in Kir6.2–/– islets. Following a single injection, plasma STZ levels were slightly less in Kir6.2–/– mice than in wild-type mice. Despite the difference in plasma STZ, wild-type and Kir6.2–/– liver accumulated the same amount of STZ, whereas Kir6.2–/– pancreas accumulated 4.1-fold less STZ than wild-type pancreas. Kir6.2–/– isolated pancreatic islets also transported less glucose than wild-type ones. Quantification of glucose transporter 2 (GLUT2) protein content by Western blot using an antibody with an epitope in the extracellular loop showed no significant difference in GLUT2 content between wild-type and Kir6.2–/– pancreatic islets. However, visualization by immunofluorescence with the same antibody gave rise to 32% less fluorescence in Kir6.2–/– pancreatic islets. The fluorescence intensity using another antibody, with an epitope in the COOH terminus, was 5.6 times less in Kir6.2–/– than in wild-type pancreatic islets. We conclude that 1) Kir6.2–/– mice are STZ resistant because of a decrease in STZ transport by GLUT2 in pancreatic β-cells and 2) the decreased transport is due to a downregulation of GLUT2 activity involving an effect at the COOH terminus.

knockout; insulin; liver; glucose transporter; glucose tolerance; diabetic model



Address for reprint requests and other correspondence: J.-M. Renaud, Dept. of Cellular and Molecular Medicine, Univ. of Ottawa, 451 Smyth Rd., Ottawa, ON, Canada K1H 8M5 (e-mail: jmrenaud{at}uottawa.ca)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.